Evidence map›Paper›PMID 26489832›Full record

ArticleBMC infectious diseases2015

Development of quality indicators and data assessment strategies for the prevention of central venous catheter-related bloodstream infections (CRBSI).

Anke Bramesfeld, Stephanie Wrede, Klaus Richter, Mareike Steen, Björn Broge, Jürgen Pauletzki, Joachim Szecsenyi

Open access · goldAbstract read
In one paragraph

Article in BMC infectious diseases, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 4 countries.

Anke BramesfeldAQUA Institute for applied quality improvement and research in health care GmbH, Maschmühlenweg 8-10, 37073, Göttingen, Germany. anke.bramesfeld@aqua-institut.de.
Stephanie WredeAQUA Institute for applied quality improvement and research in health care GmbH, Maschmühlenweg 8-10, 37073, Göttingen, Germany. stephanie.wrede@aqua-institut.de.
Klaus RichterAQUA Institute for applied quality improvement and research in health care GmbH, Maschmühlenweg 8-10, 37073, Göttingen, Germany. klaus.richter@aqua-institut.de.
Mareike SteenAQUA Institute for applied quality improvement and research in health care GmbH, Maschmühlenweg 8-10, 37073, Göttingen, Germany. Mareike.steen@aqua-institut.de.
Björn BrogeAQUA Institute for applied quality improvement and research in health care GmbH, Maschmühlenweg 8-10, 37073, Göttingen, Germany. bjoern.broge@aqua-institut.de.
Jürgen PauletzkiAQUA Institute for applied quality improvement and research in health care GmbH, Maschmühlenweg 8-10, 37073, Göttingen, Germany. Juergen.pauletzki@aqua-institut.de.
Joachim SzecsenyiAQUA Institute for applied quality improvement and research in health care GmbH, Maschmühlenweg 8-10, 37073, Göttingen, Germany. Joachim.szecsenyi@aqua-institut.de.
Aquatic Systems (United States) · USHeidelberg University · DEInstitute for Quality and Efficiency in Health Care · DEInstitute for Research and Development · LKMedizinische Hochschule Hannover · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe number of catheter related bloodstream infections (CRBSI) could be reduced and the outcome improved if specific standards in the quality of care were maintained. Therefore, the development of quality assurance (QA) procedures was commissioned to be included in the national mandatory QA programme in Germany.

methodsIndicators representing quality deficiencies and potential for improvement of quality in relation to prevention and management of central venous catheters (CVC) were developed by (1) evidence-based literature searches and the compiling of an indicator register; (2) a multi-professional expert panel including patient representatives who selected indicators from this register by using a modified RAND/UCLA Appropriateness Method; (3) defining methods for data assessment, risk adjustment and feedback of indicator results to service providers; and (4) consulting all relevant medical societies and other stakeholders with regard to the QA procedures that had been developed.

resultsThirty-two indicators for CRBSI prevention and management were eventually approved by the expert panel. These indicators represent quality of care at predefined points with regard to indication, insertion and care of CVCs, management of sepsis, general hygiene and training of health care personnel. Fourteen indicators represent processes, together with 7 representing structures and 11 outcomes. For assessing these indicators, data was obtained from four sources: claims data from health insurance funds, routine claims data from hospital electronic information systems, case specific longitudinal documentation from service providers and cross-sectional annual assessment of structures.

conclusionsIt was possible to develop indicators for mandatory QA procedures on CRBSI that take into account the different perspectives of all stakeholders involved. Despite efforts to use routine data for documentation wherever possible, most indicators required extra documentation.

Indexed as

Quality Indicators, Health CareBacteremiaCatheter-Related InfectionsCentral Venous CathetersCross-Sectional StudiesGermanyHumansRisk FactorsSepsisTreatment Outcome

Identifiers

PMID26489832
PMCPMC4618155
OpenAlexW2115335325

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.